Milrinone

Milrinone (pronounced: mil-ri-noan) is a type of medication classified under the category of Phosphodiesterase 3 inhibitors. It is primarily used in the treatment of heart failure and cardiogenic shock.

Etymology

The term "Milrinone" is derived from the chemical name, Methyl IsoLeucine RInol ONE.

Pharmacology

Milrinone works by inhibiting the action of an enzyme called phosphodiesterase 3 (PDE3). This inhibition leads to an increase in the levels of cyclic adenosine monophosphate (cAMP) within the heart muscle cells, resulting in a stronger and more efficient heartbeat.

Usage

Milrinone is used in the treatment of severe congestive heart failure and cardiogenic shock, a condition where the heart is unable to pump sufficient blood to meet the body's needs. It is often used when other treatments have failed to produce the desired results.

Side Effects

Like all medications, Milrinone can cause side effects. Some of the most common side effects include arrhythmia, hypotension, and angina.

Related Terms

• Phosphodiesterase 3 inhibitors
• Heart failure
• Cardiogenic shock
• Arrhythmia
• Hypotension
• Angina

External links

• Medical encyclopedia article on Milrinone
• Wikipedia's article - Milrinone

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski